Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20736987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Use of Oral Probiotics to Reduce Urinary Oxalate Excretion
Conditions: Nephrolithiasis;   Hyperoxaluria;   Crohn's Disease
Interventions: Dietary Supplement: Oxadrop;   Dietary Supplement: Agri-King Synbiotic (AKSB);   Other: Placebo

Indicates status has not been verified in more than two years